_id
690daf08ccc777a4e85d0ad4
Ticker
ANL
Name
Adlai Nortye Ltd. American Depositary Shares
Exchange
NASDAQ
Address
Ugland House, Grand Cayman, Cayman Islands, KY1-1104
Country
USA
Sector
Healthcare
Industry
Biotechnology
Currency
USD
Website
https://www.adlainortye.com
Description
Adlai Nortye Ltd., a clinical-stage biotechnology company, engages in the research and development of pharmaceutical products. Its lead product is AN2025, a pan-phosphoinositide 3-kinase inhibitor, which is in Phase III clinical trials for the treatment of recurrent or metastatic head and neck squamous cell carcinomas. The company is also developing AN0025, a small molecule prostaglandin E receptor 4 antagonist to modulate the tumor microenvironment that is in a Phase Ib clinical trial for the treatment of recurrent non-small cell lung cancer and urothelial cancer after anti-PD-1/PD-L1 treatments, recurrent triple-negative breast cancer, microsatellite stable colorectal cancer, and cervical cancer after standard of care treatments; and AN4005, an oral small-molecule PD-L1 inhibitor, which is in Phase I clinical trials to induce and stabilize PD-L1 dimerization and disrupt the interaction between PD-1 and PD-L1. Its preclinical candidates include AN8025, a multifunctional antibody as T cell and antigen-presenting cell modulator; and AN9025, an oral small molecule pan-KRAS inhibitor. The company was founded in 2004 and is based in Grand Cayman, the Cayman Islands.
Last Close
1.79
Volume
41158
Current Price
1.85
Change
-0.053
Last Updated
2026-01-22T07:43:35.063Z
Image
data:image/webp;base64,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
Ipo Date
2023-09-29T00:00:00.000Z
Market Cap
68265496
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
0.996
Sentiment Sources
1
Rating
3
Target Price
9
Strong Buy
0
Buy
0
Hold
1
Sell
0
Strong Sell
0
Current Quarter
2024-06-30
Revenue
745000
Cost Of Revenue
-
Gross Profit
745000
Operating Expenses
14079000
Operating Income
-14621500
Interest Expense
-
Pretax Income
-13806000
Net Income
-13806000
Eps
-1.5853343596017395
Dividends Per Share
-
Shares Outstanding
31236934
Income Tax Expense
-
EBITDA
-14355500
Operating Margin
-1962.6174496644296
Total Other Income Expense Net
815500
Cash
97980000
Short Term Investments
7000
Receivables
2295000
Inventories
-
Total Current Assets
100282000
Property Plant Equipment
2878000
Total Assets
107682000
Payables
10996000
Short Term Debt
38891000
Long Term Debt
-
Total Liabilities
54314000
Equity
53370000
Bs_currency_symbol
USD
Depreciation
502499
Change In Working Capital
-511499
Cash From Operations
-14185500
Capital Expenditures
61000
Cash From Investing
13757000
Cash From Financing
3755000
Net Change In Cash
3244000
Cf_currency_symbol
-
PE
-
PB
0.3018710895634251
ROE
-25.86846543001686
ROA
-12.821084303783362
FCF
-14246500
Fcf Percent
-19.122818791946308
Piotroski FScore
1
Health Score
24
Deep Value Investing Score
5.5
Defensive Investing Score
6
Dividend Investing Score
1.5
Economic Moat Investing Score
4.3
Garp Investing Score
1.5
Growth Investing Score
1
Momentum Investing Score
4.5
Net Net Investing Score
3
Quality Investing Score
2
Value Investing Score
4.5
Quarters > 0 > quarter
2024-06-30
Quarters > 0 > income Statement > revenue
745000
Quarters > 0 > income Statement > cost Of Revenue
-
Quarters > 0 > income Statement > gross Profit
745000
Quarters > 0 > income Statement > operating Expenses
14079000
Quarters > 0 > income Statement > operating Income
-14621500
Quarters > 0 > income Statement > interest Expense
-
Quarters > 0 > income Statement > pretax Income
-13806000
Quarters > 0 > income Statement > net Income
-13806000
Quarters > 0 > income Statement > eps
-1.5853343596017395
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
8708573
Quarters > 0 > income Statement > income Tax Expense
-
Quarters > 0 > income Statement > EBITDA
-14355500
Quarters > 0 > income Statement > operating Margin
-1962.6174496644296
Quarters > 0 > income Statement > total Other Income Expense Net
815500
Quarters > 0 > income Statement > currency_symbol
-
Quarters > 0 > balance Sheet > cash
97980000
Quarters > 0 > balance Sheet > short Term Investments
7000
Quarters > 0 > balance Sheet > receivables
2295000
Quarters > 0 > balance Sheet > inventories
-
Quarters > 0 > balance Sheet > total Current Assets
100282000
Quarters > 0 > balance Sheet > property Plant Equipment
2878000
Quarters > 0 > balance Sheet > total Assets
107682000
Quarters > 0 > balance Sheet > payables
10996000
Quarters > 0 > balance Sheet > short Term Debt
38891000
Quarters > 0 > balance Sheet > long Term Debt
-
Quarters > 0 > balance Sheet > total Liabilities
54314000
Quarters > 0 > balance Sheet > equity
53370000
Quarters > 0 > balance Sheet > currency_symbol
USD
Quarters > 0 > cash Flow > net Income
-13806000
Quarters > 0 > cash Flow > depreciation
502499
Quarters > 0 > cash Flow > change In Working Capital
-511499
Quarters > 0 > cash Flow > cash From Operations
-14185500
Quarters > 0 > cash Flow > capital Expenditures
61000
Quarters > 0 > cash Flow > cash From Investing
13757000
Quarters > 0 > cash Flow > cash From Financing
3755000
Quarters > 0 > cash Flow > net Change In Cash
3244000
Quarters > 0 > cash Flow > currency_symbol
-
Quarters > 0 > ratios > PE
-1.5853343596017395
Quarters > 0 > ratios > PB
0.3018710895634251
Quarters > 0 > ratios > ROE
-25.86846543001686
Quarters > 0 > ratios > ROA
-12.821084303783362
Quarters > 0 > ratios > FCF
-14246500
Quarters > 0 > ratios > Piotroski FScore
1
Quarters > 0 > ratios > fcf Percent
-19.122818791946308
Quarters > 0 > health Score
24
Quarters > 1 > quarter
2024-03-31
Quarters > 1 > income Statement > revenue
745000
Quarters > 1 > income Statement > cost Of Revenue
-
Quarters > 1 > income Statement > gross Profit
745000
Quarters > 1 > income Statement > operating Expenses
14079000
Quarters > 1 > income Statement > operating Income
-14621500
Quarters > 1 > income Statement > interest Expense
-
Quarters > 1 > income Statement > pretax Income
-13806000
Quarters > 1 > income Statement > net Income
-13806000
Quarters > 1 > income Statement > eps
-1.5853343596017395
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
8708573
Quarters > 1 > income Statement > income Tax Expense
321500
Quarters > 1 > income Statement > EBITDA
-14355500
Quarters > 1 > income Statement > operating Margin
-1962.6174496644296
Quarters > 1 > income Statement > total Other Income Expense Net
815500
Quarters > 1 > income Statement > currency_symbol
-
Quarters > 1 > balance Sheet > cash
97980000
Quarters > 1 > balance Sheet > short Term Investments
7000
Quarters > 1 > balance Sheet > receivables
359000
Quarters > 1 > balance Sheet > inventories
-
Quarters > 1 > balance Sheet > total Current Assets
100282000
Quarters > 1 > balance Sheet > property Plant Equipment
2878000
Quarters > 1 > balance Sheet > total Assets
107682000
Quarters > 1 > balance Sheet > payables
14348000
Quarters > 1 > balance Sheet > short Term Debt
38891000
Quarters > 1 > balance Sheet > long Term Debt
-
Quarters > 1 > balance Sheet > total Liabilities
54314000
Quarters > 1 > balance Sheet > equity
53370000
Quarters > 1 > balance Sheet > currency_symbol
-
Quarters > 1 > cash Flow > net Income
-13806000
Quarters > 1 > cash Flow > depreciation
502499
Quarters > 1 > cash Flow > change In Working Capital
-511499
Quarters > 1 > cash Flow > cash From Operations
-14185500
Quarters > 1 > cash Flow > capital Expenditures
61000
Quarters > 1 > cash Flow > cash From Investing
13757000
Quarters > 1 > cash Flow > cash From Financing
3755000
Quarters > 1 > cash Flow > net Change In Cash
3244000
Quarters > 1 > cash Flow > currency_symbol
-
Quarters > 1 > ratios > PE
-1.5853343596017395
Quarters > 1 > ratios > PB
0.3018710895634251
Quarters > 1 > ratios > ROE
-25.86846543001686
Quarters > 1 > ratios > ROA
-12.821084303783362
Quarters > 1 > ratios > FCF
-14246500
Quarters > 1 > ratios > Piotroski FScore
1
Quarters > 1 > ratios > fcf Percent
-19.122818791946308
Quarters > 1 > health Score
24
Quarters > 2 > quarter
2023-12-31
Quarters > 2 > income Statement > revenue
2500000
Quarters > 2 > income Statement > cost Of Revenue
-
Quarters > 2 > income Statement > gross Profit
2500000
Quarters > 2 > income Statement > operating Expenses
15130500
Quarters > 2 > income Statement > operating Income
-17713000
Quarters > 2 > income Statement > interest Expense
-
Quarters > 2 > income Statement > pretax Income
-12905000
Quarters > 2 > income Statement > net Income
-13226500
Quarters > 2 > income Statement > eps
-0.6478905996812495
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
20414712
Quarters > 2 > income Statement > income Tax Expense
321500
Quarters > 2 > income Statement > EBITDA
-17429500
Quarters > 2 > income Statement > operating Margin
-708.52
Quarters > 2 > income Statement > total Other Income Expense Net
4808000
Quarters > 2 > income Statement > currency_symbol
-
Quarters > 2 > balance Sheet > cash
91492000
Quarters > 2 > balance Sheet > short Term Investments
7224000
Quarters > 2 > balance Sheet > receivables
-
Quarters > 2 > balance Sheet > inventories
-
Quarters > 2 > balance Sheet > total Current Assets
101195000
Quarters > 2 > balance Sheet > property Plant Equipment
3800000
Quarters > 2 > balance Sheet > total Assets
130189000
Quarters > 2 > balance Sheet > payables
14348000
Quarters > 2 > balance Sheet > short Term Debt
30357000
Quarters > 2 > balance Sheet > long Term Debt
-
Quarters > 2 > balance Sheet > total Liabilities
50786000
Quarters > 2 > balance Sheet > equity
79403000
Quarters > 2 > balance Sheet > currency_symbol
-
Quarters > 2 > cash Flow > net Income
-13226500
Quarters > 2 > cash Flow > depreciation
517499
Quarters > 2 > cash Flow > change In Working Capital
-3076500
Quarters > 2 > cash Flow > cash From Operations
-19164500
Quarters > 2 > cash Flow > capital Expenditures
57500
Quarters > 2 > cash Flow > cash From Investing
-
Quarters > 2 > cash Flow > cash From Financing
50638500
Quarters > 2 > cash Flow > net Change In Cash
15732001
Quarters > 2 > cash Flow > currency_symbol
USD
Quarters > 2 > ratios > PE
-0.6478905996812495
Quarters > 2 > ratios > PB
0.47563967608276764
Quarters > 2 > ratios > ROE
-16.65743107943025
Quarters > 2 > ratios > ROA
-10.159460476691578
Quarters > 2 > ratios > FCF
-19222000
Quarters > 2 > ratios > Piotroski FScore
1
Quarters > 2 > ratios > fcf Percent
-7.6888
Quarters > 2 > health Score
30
Quarters > 3 > quarter
2023-09-30
Quarters > 3 > income Statement > revenue
2500000
Quarters > 3 > income Statement > cost Of Revenue
-
Quarters > 3 > income Statement > gross Profit
2500000
Quarters > 3 > income Statement > operating Expenses
15130500
Quarters > 3 > income Statement > operating Income
-17713000
Quarters > 3 > income Statement > interest Expense
-
Quarters > 3 > income Statement > pretax Income
-12905000
Quarters > 3 > income Statement > net Income
-13226500
Quarters > 3 > income Statement > eps
-1.94387061653612
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
6804208
Quarters > 3 > income Statement > income Tax Expense
321500
Quarters > 3 > income Statement > EBITDA
-17429500
Quarters > 3 > income Statement > operating Margin
-708.52
Quarters > 3 > income Statement > total Other Income Expense Net
4808000
Quarters > 3 > income Statement > currency_symbol
-
Quarters > 3 > balance Sheet > cash
91492000
Quarters > 3 > balance Sheet > short Term Investments
7224000
Quarters > 3 > balance Sheet > receivables
-
Quarters > 3 > balance Sheet > inventories
-
Quarters > 3 > balance Sheet > total Current Assets
101195000
Quarters > 3 > balance Sheet > property Plant Equipment
3800000
Quarters > 3 > balance Sheet > total Assets
130189000
Quarters > 3 > balance Sheet > payables
14348000
Quarters > 3 > balance Sheet > short Term Debt
30357000
Quarters > 3 > balance Sheet > long Term Debt
-
Quarters > 3 > balance Sheet > total Liabilities
50786000
Quarters > 3 > balance Sheet > equity
79403000
Quarters > 3 > balance Sheet > currency_symbol
-
Quarters > 3 > cash Flow > net Income
-13226500
Quarters > 3 > cash Flow > depreciation
517499
Quarters > 3 > cash Flow > change In Working Capital
-3076500
Quarters > 3 > cash Flow > cash From Operations
-19164500
Quarters > 3 > cash Flow > capital Expenditures
57500
Quarters > 3 > cash Flow > cash From Investing
-16160499
Quarters > 3 > cash Flow > cash From Financing
50638500
Quarters > 3 > cash Flow > net Change In Cash
15732000
Quarters > 3 > cash Flow > currency_symbol
-
Quarters > 3 > ratios > PE
-1.94387061653612
Quarters > 3 > ratios > PB
0.15853034268226643
Quarters > 3 > ratios > ROE
-16.65743107943025
Quarters > 3 > ratios > ROA
-10.159460476691578
Quarters > 3 > ratios > FCF
-19222000
Quarters > 3 > ratios > Piotroski FScore
1
Quarters > 3 > ratios > fcf Percent
-7.6888
Quarters > 3 > health Score
30
Annuals > 0 > quarter
2024-12-31
Annuals > 0 > income Statement > revenue
0
Annuals > 0 > income Statement > cost Of Revenue
1870937
Annuals > 0 > income Statement > gross Profit
-1870937
Annuals > 0 > income Statement > operating Expenses
53024582
Annuals > 0 > income Statement > operating Income
-54895520
Annuals > 0 > income Statement > interest Expense
1944975
Annuals > 0 > income Statement > pretax Income
-51895016
Annuals > 0 > income Statement > net Income
-51895016
Annuals > 0 > income Statement > eps
-4.8765004901400655
Annuals > 0 > income Statement > dividends Per Share
0
Annuals > 0 > income Statement > shares Outstanding
10641856
Annuals > 0 > income Statement > income Tax Expense
-
Annuals > 0 > income Statement > EBITDA
-48075103
Annuals > 0 > income Statement > operating Margin
-
Annuals > 0 > income Statement > total Other Income Expense Net
3000503
Annuals > 0 > income Statement > currency_symbol
USD
Annuals > 0 > balance Sheet > cash
60902000
Annuals > 0 > balance Sheet > short Term Investments
7000
Annuals > 0 > balance Sheet > receivables
1174000
Annuals > 0 > balance Sheet > inventories
-
Annuals > 0 > balance Sheet > total Current Assets
64064000
Annuals > 0 > balance Sheet > property Plant Equipment
2705000
Annuals > 0 > balance Sheet > total Assets
71270000
Annuals > 0 > balance Sheet > payables
10146000
Annuals > 0 > balance Sheet > short Term Debt
26801000
Annuals > 0 > balance Sheet > long Term Debt
-
Annuals > 0 > balance Sheet > total Liabilities
45785000
Annuals > 0 > balance Sheet > equity
25485000
Annuals > 0 > balance Sheet > currency_symbol
USD
Annuals > 0 > cash Flow > net Income
-51869000
Annuals > 0 > cash Flow > depreciation
1870000
Annuals > 0 > cash Flow > change In Working Capital
-5540000
Annuals > 0 > cash Flow > cash From Operations
-51819000
Annuals > 0 > cash Flow > capital Expenditures
170000
Annuals > 0 > cash Flow > cash From Investing
28065000
Annuals > 0 > cash Flow > cash From Financing
-6579000
Annuals > 0 > cash Flow > net Change In Cash
-30590000
Annuals > 0 > cash Flow > currency_symbol
USD
Annuals > 0 > ratios > PE
-4.8765004901400655
Annuals > 0 > ratios > PB
0.7725106376299784
Annuals > 0 > ratios > ROE
-203.62964881302727
Annuals > 0 > ratios > ROA
-72.81467096955241
Annuals > 0 > ratios > FCF
-51989000
Annuals > 0 > ratios > Piotroski FScore
0
Annuals > 0 > ratios > fcf Percent
-
Annuals > 0 > health Score
23
Annuals > 1 > quarter
2023-12-31
Annuals > 1 > income Statement > revenue
4995653
Annuals > 1 > income Statement > cost Of Revenue
2220068
Annuals > 1 > income Statement > gross Profit
5000000
Annuals > 1 > income Statement > operating Expenses
72551000
Annuals > 1 > income Statement > operating Income
-67551000
Annuals > 1 > income Statement > interest Expense
791000
Annuals > 1 > income Statement > pretax Income
-104228000
Annuals > 1 > income Statement > net Income
-104871000
Annuals > 1 > income Statement > eps
-15.412668160644118
Annuals > 1 > income Statement > dividends Per Share
0
Annuals > 1 > income Statement > shares Outstanding
6804208
Annuals > 1 > income Statement > income Tax Expense
643000
Annuals > 1 > income Statement > EBITDA
-101215000
Annuals > 1 > income Statement > operating Margin
-1352.1955988536433
Annuals > 1 > income Statement > total Other Income Expense Net
-36677000
Annuals > 1 > income Statement > currency_symbol
USD
Annuals > 1 > balance Sheet > cash
91492018
Annuals > 1 > balance Sheet > short Term Investments
7007000
Annuals > 1 > balance Sheet > receivables
359000
Annuals > 1 > balance Sheet > inventories
1
Annuals > 1 > balance Sheet > total Current Assets
101195000
Annuals > 1 > balance Sheet > property Plant Equipment
3800000
Annuals > 1 > balance Sheet > total Assets
130189000
Annuals > 1 > balance Sheet > payables
14348000
Annuals > 1 > balance Sheet > short Term Debt
31079000
Annuals > 1 > balance Sheet > long Term Debt
-
Annuals > 1 > balance Sheet > total Liabilities
50786000
Annuals > 1 > balance Sheet > equity
79403015
Annuals > 1 > balance Sheet > currency_symbol
USD
Annuals > 1 > cash Flow > net Income
-104871000
Annuals > 1 > cash Flow > depreciation
2220068
Annuals > 1 > cash Flow > change In Working Capital
6124000
Annuals > 1 > cash Flow > cash From Operations
-56652000
Annuals > 1 > cash Flow > capital Expenditures
200000
Annuals > 1 > cash Flow > cash From Investing
-10954000
Annuals > 1 > cash Flow > cash From Financing
116240000
Annuals > 1 > cash Flow > net Change In Cash
48734000
Annuals > 1 > cash Flow > currency_symbol
USD
Annuals > 1 > ratios > PE
-15.412668160644118
Annuals > 1 > ratios > PB
0.15853031273434642
Annuals > 1 > ratios > ROE
-132.0743299231144
Annuals > 1 > ratios > ROA
-80.55288849288343
Annuals > 1 > ratios > FCF
-56852000
Annuals > 1 > ratios > Piotroski FScore
1
Annuals > 1 > ratios > fcf Percent
-11.38029402762762
Annuals > 1 > health Score
30
Annuals > 2 > quarter
2022-12-31
Annuals > 2 > income Statement > revenue
0
Annuals > 2 > income Statement > cost Of Revenue
2038574
Annuals > 2 > income Statement > gross Profit
-2038574
Annuals > 2 > income Statement > operating Expenses
58907000
Annuals > 2 > income Statement > operating Income
-67270000
Annuals > 2 > income Statement > interest Expense
433000
Annuals > 2 > income Statement > pretax Income
-58790000
Annuals > 2 > income Statement > net Income
-58790000
Annuals > 2 > income Statement > eps
-6.932783018867925
Annuals > 2 > income Statement > dividends Per Share
0
Annuals > 2 > income Statement > shares Outstanding
8480000
Annuals > 2 > income Statement > income Tax Expense
8312000
Annuals > 2 > income Statement > EBITDA
-57406000
Annuals > 2 > income Statement > operating Margin
-
Annuals > 2 > income Statement > total Other Income Expense Net
8480000
Annuals > 2 > income Statement > currency_symbol
USD
Annuals > 2 > balance Sheet > cash
42758000
Annuals > 2 > balance Sheet > short Term Investments
21287000
Annuals > 2 > balance Sheet > receivables
346000
Annuals > 2 > balance Sheet > inventories
-3
Annuals > 2 > balance Sheet > total Current Assets
66303000
Annuals > 2 > balance Sheet > property Plant Equipment
5875000
Annuals > 2 > balance Sheet > total Assets
72594000
Annuals > 2 > balance Sheet > payables
13098000
Annuals > 2 > balance Sheet > short Term Debt
5308000
Annuals > 2 > balance Sheet > long Term Debt
-
Annuals > 2 > balance Sheet > total Liabilities
313887000
Annuals > 2 > balance Sheet > equity
-241293000
Annuals > 2 > balance Sheet > currency_symbol
USD
Annuals > 2 > cash Flow > net Income
-58790000
Annuals > 2 > cash Flow > depreciation
2041000
Annuals > 2 > cash Flow > change In Working Capital
15247000
Annuals > 2 > cash Flow > cash From Operations
-43223000
Annuals > 2 > cash Flow > capital Expenditures
1268000
Annuals > 2 > cash Flow > cash From Investing
28376000
Annuals > 2 > cash Flow > cash From Financing
-6780000
Annuals > 2 > cash Flow > net Change In Cash
-21373000
Annuals > 2 > cash Flow > currency_symbol
USD
Annuals > 2 > ratios > PE
-6.932783018867925
Annuals > 2 > ratios > PB
-0.06501639086090355
Annuals > 2 > ratios > ROE
24.36456921667848
Annuals > 2 > ratios > ROA
-80.98465437914979
Annuals > 2 > ratios > FCF
-44491000
Annuals > 2 > ratios > Piotroski FScore
0
Annuals > 2 > ratios > fcf Percent
-
Annuals > 2 > health Score
30
Annuals > 3 > quarter
2021-12-31
Annuals > 3 > income Statement > revenue
45726000
Annuals > 3 > income Statement > cost Of Revenue
-
Annuals > 3 > income Statement > gross Profit
45726000
Annuals > 3 > income Statement > operating Expenses
54372000
Annuals > 3 > income Statement > operating Income
-8646000
Annuals > 3 > income Statement > interest Expense
1338774
Annuals > 3 > income Statement > pretax Income
-56678000
Annuals > 3 > income Statement > net Income
-56678000
Annuals > 3 > income Statement > eps
-6.683726415094339
Annuals > 3 > income Statement > dividends Per Share
0
Annuals > 3 > income Statement > shares Outstanding
8480000
Annuals > 3 > income Statement > income Tax Expense
-46188000
Annuals > 3 > income Statement > EBITDA
-53584034
Annuals > 3 > income Statement > operating Margin
-18.908279753313213
Annuals > 3 > income Statement > total Other Income Expense Net
-48032000
Annuals > 3 > income Statement > currency_symbol
USD
Annuals > 3 > balance Sheet > cash
64131000
Annuals > 3 > balance Sheet > short Term Investments
53809000
Annuals > 3 > balance Sheet > receivables
1931000
Annuals > 3 > balance Sheet > inventories
100
Annuals > 3 > balance Sheet > total Current Assets
124544000
Annuals > 3 > balance Sheet > property Plant Equipment
6589000
Annuals > 3 > balance Sheet > total Assets
131685000
Annuals > 3 > balance Sheet > payables
2981000
Annuals > 3 > balance Sheet > short Term Debt
11291000
Annuals > 3 > balance Sheet > long Term Debt
-
Annuals > 3 > balance Sheet > total Liabilities
317113000
Annuals > 3 > balance Sheet > equity
-185428000
Annuals > 3 > balance Sheet > currency_symbol
USD
Annuals > 3 > cash Flow > net Income
-56678000
Annuals > 3 > cash Flow > depreciation
1828000
Annuals > 3 > cash Flow > change In Working Capital
250000
Annuals > 3 > cash Flow > cash From Operations
-3034000
Annuals > 3 > cash Flow > capital Expenditures
1120000
Annuals > 3 > cash Flow > cash From Investing
-54857000
Annuals > 3 > cash Flow > cash From Financing
97200000
Annuals > 3 > cash Flow > net Change In Cash
39870000
Annuals > 3 > cash Flow > currency_symbol
USD
Annuals > 3 > ratios > PE
-6.683726415094339
Annuals > 3 > ratios > PB
-0.08460426688526006
Annuals > 3 > ratios > ROE
30.566041805983996
Annuals > 3 > ratios > ROA
-43.04058928503626
Annuals > 3 > ratios > FCF
-4154000
Annuals > 3 > ratios > Piotroski FScore
0
Annuals > 3 > ratios > fcf Percent
-0.09084547084809518
Annuals > 3 > health Score
30
Valuation > metrics > PE
-1.5853343596017395
Valuation > metrics > PB
0.3018710895634251
Valuation > final Score
70
Valuation > verdict
69.8% Undervalued
Profitability > metrics > ROE
-25.86846543001686
Profitability > metrics > ROA
-13.767176562094892
Profitability > metrics > Net Margin
-18.531543624161074
Profitability > final Score
0
Profitability > verdict
Weak
Risk > metrics > Debt Equity
1.017687839610268
Risk > metrics > Interest Coverage
-26.608735213830755
Risk > final Score
-76
Risk > verdict
High
Liquidity > metrics > Current Ratio
-
Liquidity > metrics > Quick Ratio
-
Liquidity > final Score
50
Liquidity > verdict
Weak
Prev Valuations > 0
70
Prev Valuations > 1
70
Prev Valuations > 2
70
Prev Profitabilities > 0
0
Prev Profitabilities > 1
0
Prev Profitabilities > 2
0
Prev Risks > 0
-76
Prev Risks > 1
32
Prev Risks > 2
32
Prev Liquidities > 0
50
Prev Liquidities > 1
50
Prev Liquidities > 2
50
Updated At
2026-01-22T07:43:35.711Z
Earnings History > 0 > period
2025-12-31
Earnings History > 0 > report Date
2026-02-25
Earnings History > 0 > date
2025-12-31
Earnings History > 0 > before After Market
-
Earnings History > 0 > currency
-
Earnings History > 0 > eps Actual
0
Earnings History > 0 > eps Estimate
0
Earnings History > 0 > eps Difference
0
Earnings History > 0 > surprise Percent
-
Earnings History > 1 > period
2025-09-30
Earnings History > 1 > report Date
2025-12-03
Earnings History > 1 > date
2025-09-30
Earnings History > 1 > before After Market
-
Earnings History > 1 > currency
-
Earnings History > 1 > eps Actual
0
Earnings History > 1 > eps Estimate
0
Earnings History > 1 > eps Difference
0
Earnings History > 1 > surprise Percent
-
Earnings History > 2 > period
2025-06-30
Earnings History > 2 > report Date
2025-08-07
Earnings History > 2 > date
2025-06-30
Earnings History > 2 > before After Market
-
Earnings History > 2 > currency
-
Earnings History > 2 > eps Actual
-0.18
Earnings History > 2 > eps Estimate
0
Earnings History > 2 > eps Difference
-0.18
Earnings History > 2 > surprise Percent
-
Earnings History > 3 > period
2025-03-31
Earnings History > 3 > report Date
2025-04-30
Earnings History > 3 > date
2025-03-31
Earnings History > 3 > before After Market
-
Earnings History > 3 > currency
-
Earnings History > 3 > eps Actual
-0.64
Earnings History > 3 > eps Estimate
-0.63
Earnings History > 3 > eps Difference
-0.01
Earnings History > 3 > surprise Percent
-1.5873
Earnings History > 4 > period
2024-09-30
Earnings History > 4 > report Date
2024-11-27
Earnings History > 4 > date
2024-09-30
Earnings History > 4 > before After Market
-
Earnings History > 4 > currency
-
Earnings History > 4 > eps Actual
0
Earnings History > 4 > eps Estimate
-0.62
Earnings History > 4 > eps Difference
0.62
Earnings History > 4 > surprise Percent
100
Earnings History > 5 > period
2024-06-30
Earnings History > 5 > report Date
2024-08-08
Earnings History > 5 > date
2024-06-30
Earnings History > 5 > before After Market
-
Earnings History > 5 > currency
-
Earnings History > 5 > eps Actual
-0.35
Earnings History > 5 > eps Estimate
-0.61
Earnings History > 5 > eps Difference
0.26
Earnings History > 5 > surprise Percent
42.623
Earnings History > 6 > period
2023-12-31
Earnings History > 6 > report Date
2024-02-28
Earnings History > 6 > date
2023-12-31
Earnings History > 6 > before After Market
-
Earnings History > 6 > currency
USD
Earnings History > 6 > eps Actual
-0.38
Earnings History > 6 > eps Estimate
-0.38
Earnings History > 6 > eps Difference
0
Earnings History > 6 > surprise Percent
0
Earnings History > 7 > period
2023-09-30
Earnings History > 7 > report Date
2023-11-29
Earnings History > 7 > date
2023-09-30
Earnings History > 7 > before After Market
-
Earnings History > 7 > currency
USD
Earnings History > 7 > eps Actual
-0.24
Earnings History > 7 > eps Estimate
-0.24
Earnings History > 7 > eps Difference
0
Earnings History > 7 > surprise Percent
0
Earnings History > 8 > period
2023-06-30
Earnings History > 8 > report Date
2023-08-30
Earnings History > 8 > date
2023-06-30
Earnings History > 8 > before After Market
-
Earnings History > 8 > currency
USD
Earnings History > 8 > eps Actual
-1.94
Earnings History > 8 > eps Estimate
0
Earnings History > 8 > eps Difference
-1.94
Earnings History > 8 > surprise Percent
-
Adlai Nortye Ltd., a clinical-stage biotechnology company, engages in the research and development of pharmaceutical products. Its lead product is AN2025, a pan-phosphoinositide 3-kinase inhibitor, which is in Phase III clinical trials for the treatment of recurrent or metastatic head and neck squamous cell carcinomas. The company is also developing AN0025, a small molecule prostaglandin E receptor 4 antagonist to modulate the tumor microenvironment that is in a Phase Ib clinical trial for the treatment of recurrent non-small cell lung cancer and urothelial cancer after anti-PD-1/PD-L1 treatments, recurrent triple-negative breast cancer, microsatellite stable colorectal cancer, and cervical cancer after standard of care treatments; and AN4005, an oral small-molecule PD-L1 inhibitor, which is in Phase I clinical trials to induce and stabilize PD-L1 dimerization and disrupt the interaction between PD-1 and PD-L1. Its preclinical candidates include AN8025, a multifunctional antibody as T cell and antigen-presenting cell modulator; and AN9025, an oral small molecule pan-KRAS inhibitor. The company was founded in 2004 and is based in Grand Cayman, the Cayman Islands.
Stock Price
$0.00
decrease compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/APrince Harry Accuses Tabloids Of Making Wife's Life 'Absolute Misery' Barron's
Read more →Showing 2 of 10
(Last Updated 2024-06-30)
Rating:
HOLD
Target Price:
$9
Analyst Picks
Strong Buy
0
Buy
0
Hold
1
Sell
0
Strong Sell
0
Sentiment:
Bullish
(Last Updated 2024-06-30)
Health Score
Price to Book Ratio (P/B)
-
Very Low
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very Low
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Free Cash Flow - Revenue % (FCF)
-
Very Low
Low ≤ 5%
High ≥ 15%
Debt to Equity
-
Very Low
Low ≥ 1
High ≤ 0.3
* Institutions hold a combined 0.00% of the total shares of Adlai Nortye Ltd. American Depositary Shares
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
2025-12-31
EPS Estimate
0
Date
2025-09-30
EPS Actual
0
EPS Estimate
0
EPS Difference
0
Surprise Percent
0%
(Last Updated 2024-06-30)
(Last Updated 2024-06-30)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2024-06-30)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2024-06-30)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.